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Summary
 
Many pathogenic bacteria can use heme compounds as a source of iron. Pathogenic 
 
Escherichia
coli
 
 strains are capable of using hemoglobin as an iron source. However, the mechanism of
heme acquisition from hemoglobin is not understood for this microorganism. We present the
first molecular characterization of a hemoglobin protease (Hbp) from a human pathogenic 
 
E
 
.
 
coli
 
 strain. The enzyme also appeared to be a heme-binding protein. Affinity purification of this
bifunctional protein enabled us to identify the extracellular gene product, and to clone and an-
alyze its gene. A purification procedure developed for Hbp allowed us to perform functional
studies. The protein interacted with hemoglobin, degraded it and subsequently bound the re-
leased heme. These results suggest that the protein is involved in heme acquisition by this hu-
man pathogen. Hbp belongs to the so-called IgA1 protease-like proteins, as indicated by the
kinetics of its membrane transfer and DNA sequence similarity. The gene of this protein ap-
pears to be located on the large pColV-K30 episome, that only has been isolated from human
and animal pathogens. All these characteristics indicate that Hbp may be an important virulence
factor that may play a significant role in the pathogenesis of 
 
E
 
.
 
 coli
 
 infections.
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T
 
he low concentration of free iron in the mucous
membranes and in tissues is one of the first lines of
host defense against bacterial infection. In humans, the ma-
jority of iron is located intracellularly complexed in ferritin,
hemoglobin or heme proteins. Hemoglobin and heme,
when released by lysis of erythrocytes, are bound by the
plasma proteins haptoglobin and hemopexin, respectively.
The small quantities of extracellular iron are complexed to
carrier proteins like transferrin present in serum and lacto-
ferrin which is present within mucosal surfaces (1, 2).
Therefore, possession of specialized iron acquisition systems
is a prerequisite for successful multiplication of pathogenic
bacteria in their host.
The most common sites of human infections due to 
 
Esch-
erichia coli
 
 are the gastrointestinal and urinary tract. Fur-
thermore, this microorganism is also a well-recognized
cause of septicemia and wound infections. Ferric iron,
heme, and hemoglobin significantly enhance the suscepti-
bility of animals and humans to 
 
E
 
.
 
 coli
 
 infections (3, 4), and
several high affinity iron uptake systems have been identi-
fied (1, 5). The molecular mechanisms of these iron uptake
systems have been studied thoroughly. One way to seques-
ter iron involves the synthesis of siderophores and specific
transport systems for the uptake of the iron-loaded sidero-
phores into the cell. Siderophores like enterobactin and
aerobactin are able to remove iron from transferrin or
lactoferrin. A large number of pathogenic bacterial species
use heme compounds as a source of iron, and various outer
membrane proteins have been isolated and characterized
which proposed function is to bind heme to the bacterial
cell surface (2, 6). In these systems the outer membrane re-
ceptor directly recognizes the heme compounds. A second
more complex way to obtain heme involves an extracellu-
lar protein that binds heme and shuttles it back to a specific
outer membrane receptor (7). This so-called hemophore-
dependent heme acquisition system has been detected in
 
Haemophilus influenzae
 
 (8) and 
 
Serratia marcescens
 
 (9). 
 
E
 
.
 
 coli
 
can also use heme and hemoglobin as iron sources, but lit-
tle is known about the mechanisms of heme utilization in-
volved (10). The ability to use heme compounds as a
source of iron has been implicated as an important determi-
nant of virulence in 
 
E
 
.
 
 coli
 
 (11).
This study describes the molecular characterization of a
hemoglobin protease from the human pathogenic 
 
E
 
.
 
 coli
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strain EB1. This strain was isolated from an intra-abdomi-
nal wound infection (12). We present evidence that this
protein is part of a hemophore-dependent heme acquisi-
tion system. The protein interacts with hemoglobin, de-
grades it, and subsequently binds the released heme. The
protein belongs to the so-called IgA1 protease-like au-
totransporter proteins as indicated by the kinetics of its
membrane transfer and DNA sequence similarity. Since the
heme-binding protein is capable of degrading hemoglobin,
its gene was named 
 
hbp
 
 for hemoglobin protease (Hbp).
 
1
 
Materials and Methods
 
Bacterial Strains, Phages, Plasmids, and Media. E
 
.
 
 coli
 
 strain EB1
(O8-K43) is a clinical isolate from a patient with a wound infec-
tion (12). This strain was identified with the API 20E system (API
S.A., Montalieu Vercieu, France) and used as a source of chro-
mosomal and plasmid DNA for all cloning and PCR experi-
ments. 
 
E
 
.
 
 coli
 
 K-12 strain DH5
 
a
 
 (GIBCO BRL, Gaithersburg,
MD) and the plasmids pBluescript II SK
 
1
 
 (Stratagene, La Jolla,
CA) and pBR322 were used in routine cloning procedures (13).
Strain BL21 (F
 
2
 
ompT
 
r
 
2
 
B
 
m
 
2
 
B
 
) (DE3), and the plasmids pET11d
and pLysS were used for subcloning and controlled expression of
 
hbp 
 
(14). 
 
E
 
.
 
 coli
 
 strain TG1 (13) and the phage vector M13mp19
were used for shotgun cloning and preparation of DNA templates
for sequencing. The kanamycin resistance gene cartridge plasmid
pUC4-K (Pharmacia Biotech Sverige, Uppsala, Sweden) and the
vector pSG335 (15) were used in insertional mutagenesis experi-
ments. 
 
E
 
.
 
 coli
 
 strain AN299-23 (16) and plasmid pACYC184 (17)
were used in a colicin V assay and in conjugation experiments.
The plasmid pColV-K30 was isolated from strain LG1522 (18).
Cells were routinely grown in YT medium (19). To prepare Hbp
from the culture supernatant a chemically defined medium (MA-
medium) described by Miller, 1992) was used. If required, antibi-
otics were added to the culture medium (13).
 
General Methods.
 
Recombinant DNA techniques were car-
ried out as described (13). A digoxygenin labeling and detection
kit (Boehringer Mannheim GmbH, Mannheim, Germany) was
used to probe Southern blots. DNA sequencing was performed
using the Taq Dye Primer Cycle Sequencing Kit and the 373A
Automated DNA Sequencer of Applied Biosystems Inc. (Foster
City, CA). Protein concentrations were determined according to
Bradford (20) with bovine serum albumin as standard. SDS-
PAGE and immunoblotting were carried out as described by (21,
22). Bound antibodies were visualized on immunoblots by en-
hanced chemiluminescence (Nycomed Amersham, Buckingham-
shire, UK).
 
Amino Acid Sequencing of the NH
 
2
 
-terminus of Hbp.
 
1 ml of a
100
 
3 
 
concentrated culture supernatant from EB1 (see below) was
precipitated with TCA (10% vol/vol). Precipitated proteins were
separated on a SDS–polyacrylamide gel (11%), and subsequently
electroblotted onto an Immobilon-P transfer membrane filter
(Milipore Corp., Bedford, MA). The fixed proteins were stained
with Amidoblack. The Hbp band was cut out and subjected to
automated Edman degradation using the model 473A protein se-
quencer of Applied Biosystems.
 
Cloning and Sequencing of DNA.
 
Primers were prepared based
on the nucleotide sequence of 
 
tsh
 
.
 
 
 
The primers used were the
probe-forward
 
 
 
primer 5
 
9
 
-GTGTTAAGGGCGATAACC-3
 
9
 
 and
the probe-reverse primer 5
 
9
 
-CTTCTTCAAGGGTAAAGG-3
 
9
 
.
Chromosomal DNA of strain EB1 was used as a template for
these primers in PCR experiments. A PCR product of 1 kb long
was obtained (see Fig. 1) and used as a probe in Southern blot ex-
periments with the chromosomal DNA of strain EB1. A Hind-
III–EcoRI DNA fragment of 12.6 kb, that positively reacted in
this assay, was isolated and ligated into pBR322. Subsequently,
the insert of this recombinant plasmid pHE12.6 was sequenced. A
random sequencing strategy for sequencing of single stranded
DNA was used (23). The DNA of the plasmids pHE12.6 and
pET-Hbp (see below) was partially digested with Sau3A1, AluI,
or PalI and DNA fragments between 750 and 2,000 bp in length
were purified and cloned into M13mp19. Over 126 and 40
clones from pHE12.6 and pET-Hbp, respectively, were sequenced.
At least 10 clones for each kilobase of DNA. Synthesized oligo-
nucleotide primers and the cycle sequencing protocol were used on
the original double stranded DNA fragments of pHE12.6 and
pET-Hbp to complete the sequence. Each strand was sequenced at
least twice. Regions of uncertainty were resequenced in both
directions. The overall redundancy was between 6–8.
 
Cloning of the Structural hbp Gene.
 
The T7 expression system
was used for the cloning and IPTG-inducible expression of 
 
hbp
 
(14). The coding sequence of 
 
hbp 
 
was amplified by PCR using
the plasmid pHE12.6 as template DNA. 
 
Pfu
 
 DNA polymerase
and 
 
Taq
 
 Extender PCR additive were used in these experiments
as indicated by the manufacturer (Stratagene). Primers were de-
signed to introduce NcoI and BamHI restriction sites at the 5
 
9
 
and 3
 
9
 
 ends, respectively. The primers used were the 110-forward
primer 5
 
9
 
-CAATT
 
CCATGG
 
ACAGAATTTATTCTCTTCG-
CTA-3
 
9
 
, introducing a NcoI site (boldface letters), and the 110-
reverse primer 5
 
9
 
-ATATT
 
GGATCC
 
AGAGATGTGTTCAG-
GAGTTAG-3
 
9
 
, introducing a BamHI site (boldface letters). The
complete 
 
hbp 
 
gene was cloned into the expression vector pET11d
(14) using the created NcoI and BamHI sites. However, a point
mutation (boldface letters) was created at the 5
 
9
 
 end of the gene,
5
 
9
 
-ATG
 
G
 
ACAG-3
 
9
 
 instead of ATG
 
A
 
ACAG-3
 
9
 
, by the intro-
duction of 
 
hbp 
 
into the NcoI–BamHI site of pET11d. This point
mutation was reverted by using the QuickChange Site-Directed
Mutagenesis Kit (Stratagene). The constructed gene was se-
quenced to check for second site mutations. Plasmid pET-Hbp
was introduced into 
 
E
 
.
 
 coli
 
 BL21(DE3) carrying pLysS. Expres-
sion of 
 
hbp 
 
was induced by the addition of IPTG to a growing
culture as described previously (14). Furthermore, the structural
 
hbp
 
 gene was also cloned into the vector pBR322. The same pro-
cedure was followed as described above, only a different set of
primers was used. Instead of the 110-forward primer, primer
HindIII-forward in combination with the 110-reverse primer was
used. Primer HindIII-forward (5
 
9
 
-GGTTG
 
AAGCTT
 
TATGT-
GCAGGCATAACGG-3
 
9
 
) introduces a HindIII site (boldface
letters) 50 bp upstream of the putative promoter of 
 
hbp
 
. The
complete gene, including its own promoter, was cloned into
pBR322 using the created HindIII and BamHI sites. The plasmid
pBRHbp was introduced into 
 
E
 
.
 
 coli
 
 DH5
 
a
 
.
 
Site-specific Mutagenesis of hbp.
 
Knockout mutants of 
 
hbp
 
 were
created by the use of the counterselectable vector pSG335 (15).
The assembly of the suicide vectors used in this assay required a
number of intermediate constructions. The structural 
 
hbp 
 
gene
and the flanking regions of the gene were amplified by PCR us-
ing the plasmid pET-Hbp as template DNA. The primers used
were the 110-reverse primer (see above), introducing a BamHI
site and the pET-primer 5
 
9
 
-CCACGTACGTTCCTCT-3
 
9
 
. The
obtained DNA fragment was cloned into the XbaI–HindII site of
 
1
 
Abbreviations used in this paper:
 
 Hbp, hemoglobin protease; ORF, open
reading frame. 
1093
 
Otto et al.
pBluescript. The recombinant plasmid was designated pBS-Hbp.
The 
 
hbp
 
 gene in pBS-Hbp was disrupted by cloning a kanamycin
resistance cassette into the EcoRV site of the gene, obtaining the
plasmid pBS-Hbp::km
 
r
 
. The disrupted 
 
hbp
 
 gene was isolated from
pBS-Hbp::km
 
r
 
 by digesting the plasmid with the enzymes XbaI
and MluI. As a consequence of the digestion with the enzyme
MluI the disrupted 
 
hbp
 
 gene is also lacking the last 84 bp at the 3
 
9
 
end of the gene. The suicide vector pSG-Hbp4.8 was constructed
by cloning the 4.8-kb XbaI–MluI DNA fragment into the coun-
terselectable vector pSG335. The main characteristics of pSG335
are the presence of a 
 
sacB
 
 gene, which converts sucrose to a prod-
uct that is lethal to 
 
E
 
.
 
 coli
 
, and the presence of a chloramphenicol
resistance gene (15). Another suicide vector, pSG-Hbp2.2, was
assembled by cloning a 2.2-kb XbaI–MluI DNA fragment into
pSG335. This 2.2-kb DNA fragment, containing the km
 
r
 
 cassette
flanked on both sides by 
 
z
 
500 bp of the 
 
hbp
 
 gene, was obtained
by PCR. The plasmid pBS-Hbp::km
 
r
 
 was used as template DNA.
The primers used were the XbaI-forward primer 5
 
9
 
-CGATT
 
T-
CTAGACAATGATGCCCCGGTC-39, introducing a XbaI site
(boldface letters), and the MluI-reverse primer 59-CGAAAA-
CGCGTTGAAGACACTTTTATCTGC-39, introducing a MluI
site (boldface letters). The suicide vectors pSG-Hbp2.2 and pSG-
Hbp4.8 were used to transform the wild-type strain E. coli EB1
selecting for resistance to kanamycin. Single colonies were sub-
cultured to allow the necessary recombination and plasmid curing
events to occur. Then cells were plated on YT containing kana-
mycin and 3% sucrose, but lacking NaCl (15, 24). The plates
were incubated at 308C. Colonies grown on this selective me-
dium were screened for their inability to synthesize Hbp by
means of immunoblotting.
Subcellular Localization of Hbp. Subcellular fractions of strain
BL21(DE3)(pLysS, pET-Hbp) and the wild-type EB1 strain were
prepared essentially as previously described (25, 26). Cells were
collected by centrifugation, washed, and stored as frozen cells at
2308C. To obtain a total cell lysate, cells were lysed by freezing
and thawing combined with a short ultrasonic treatment (27).
Cell debris was removed from the cell lysate by centrifugation at
14,000 g for 10 min at 48C. Subsequently, soluble proteins (cyto-
plasmic and periplasmic proteins) and membranes were separated
by ultracentrifugation. The cytoplasmic membranes were separated
from outer membranes by selective solubilization of cytoplasmic
membranes using 0.5% sodium lauryl sarcosinate (Sarkosyl). For
detection of Hbp in the different subcellular fractions, immuno-
blotting was carried out with a specific anti-Hbp antiserum.
Heme-binding Assays. Heme–protein complexes in a poly-
acrylamide gel can be detected by chemiluminescence as de-
scribed (28). The supernatant of a mid-logarithmic phase culture of
EB1 was concentrated as described above. Hemin or human he-
moglobin (Sigma), to a final concentration of 0.30 mM or 1.5 mM
respectively, was added to 50 ml of concentrated culture superna-
tant. The concentration of Hbp in these mixtures was 2 mg. The
samples in 50 mM Hepes, pH 7.0 were incubated at 378C for 1 h.
Subsequently, 25 ml of the samples were run on a 11% nondena-
turing polyacrylamide gel. Potential heme-protein complexes in
the gel were detected by chemiluminescence.
Heme affinity chromatography was used to investigate the
binding specificity of Hbp for heme. Hbp produced by strain
DH5a(pHE12.6) was obtained from 1 liter of a mid-logarithmic
phase culture. 50 ml of this culture supernatant was mixed with
100 ml of hemin agarose (Sigma Chemical Co., St. Louis, MO),
as described (29). The mixtures were incubated at 48C overnight.
The gel beads were collected and washed six times with 0.5 M
NaCl and 10 mM sodium phosphate, pH 7.0. The proteins still
retained to the gelmatrix were eluted from the beads with SDS
sample buffer as described (9). The eluted proteins were analyzed
by SDS-PAGE and Coomassie R-250 staining.
Hemoglobin Protease Activity. Denatured hemoglobin as sub-
strate was used to detect an endopeptidase activity by the purified
Hbp protein and culture supernatants of the different E. coli
strains (30). The determination of the catalytic type of the pepti-
dase was performed using 3,4-dichloroisocoumarin (3,4-DCI), a
specific serine peptidase inhibitor. A new assay was developed to
determine the specificity of Hbp for hemoglobin. Purified Hbp
(0.5 mg / 50 ml) was mixed with 0.1 mg native hemoglobin in
100 mM phosphate buffer, pH 6.0. The mixture, Hbp and he-
moglobin alone were incubated at 378C for 4 h. Subsequently, 25
ml samples were run on an 8% nondenaturing polyacrylamide gel.
Hemoglobin in the gel was detected by incubating the gel first in
a chemiluminescence substrate solution and then sprinkling the
gel with a H2O2 solution to initiate heme-associated peroxidase
activity. The gel was immediately exposed to a X-Omat AR film
(Eastman Kodak Company, Rochester, NY) to visualize hemo-
globin. Subsequently, hemoglobin in this native gel was also visu-
alized by Coomassie R-250.
Antibodies. The polyclonal anti-Hbp antiserum was raised in
rabbit against a peptide which consists of 15 amino acid residues
of Hbp located in the NH2-terminal part of the protein (NEL-
GYQLFRDFAENK). Cross-reactivity was verified by immuno-
blotting in the presence or absence of the peptide against which
the antiserum was raised.
Conjugational Transfer of the EB1 pColV Plasmid. Strain AN299-23
was first transformed with pACyC184. The resulting strain
AN299-23(pACyC184) was used as recipient strain. The EB1
donor cells and recipient cells mixed in a ratio of 8:2 were al-
lowed to conjugate at 378C in a static liquid culture for 2 h.
Thereafter, cells were plated on MA-agar plates containing
chloramphenicol resulting in the loss of the EB1 donor cells. The
residual colonies were tested on their capacity to produce colicin
V. Colicin V activity of possible transconjugants was determined
by using a soft agar overlay technique as described previously
(31). Colicin-producing colonies gave a clear killing zone sur-
rounding the cell colony. E. coli AN299-23(pACYC184) was
used as a colicin V susceptible indicator strain.
Hemagglutination Assay. Hemagglutination activity of EB1
cells was assayed by their ability to agglutinate rabbit, chicken or
human erythrocytes on glass slides as described elsewhere (32).
Cells from liquid cultures as well from YT-agar plates both
grown at 26 or 378C were tested in this assay. In addition, puri-
fied Hbp (1 mg), purified outer membrane proteins (50 mg) ob-
tained from cells grown at 26 or 378C, and concentrated culture
supernatants were also tested on their ability to agglutinate the
different erythrocytes. The outer membrane vesicles were pre-
pared as described elsewhere (33).
Computer Analysis. For analysis and alignment of DNA se-
quences the following programs and packages have been used:
Gene Works 2.3, DNA Strider 1.0, Sequencher 2.1 and the
GCG-package. Putative gene products were searched for similar-
ity to sequences reported previously in nonredundant protein
data banks (NCBI BLASTX Search).
Results
Detection of an Extracellular Heme-binding Protein. E. coli
can use heme and hemoglobin as iron sources (10). In Serratia
marcescens (9), the extracellular protein HasA is involved in1094 Escherichia coli Hemoglobin Protease
the uptake of heme from hemoglobin, whilst in Hemophilus
influenzae the extracellular protein HxuA recognizes heme
bound to hemopexin (8). E. coli may also secrete proteins
that are able to scavenge heme from the environment. To
test this hypothesis, supernatant of a culture in the mid-expo-
nential phase of growth from the human pathogenic E.
coli strain EB1 was examined for the presence of extracellu-
lar heme-binding proteins. EB1 was cultured in a chemi-
cally defined medium to avoid contamination of the extra-
cellular proteins by constituents of the culture medium.
The culture supernatant was concentrated by means of ul-
trafiltration and then analyzed by SDS-PAGE. At least four
proteins with estimated molecular masses of 110, 40, 38,
and 37 kD were present (Fig. 1 B, lane 2). These proteins
were assayed for heme-binding properties. The proteins
were incubated with hemin and subsequently subjected to
nondenaturing PAGE. Heme–protein complexes in the gel
were visualized by chemiluminescence. One prominent
heme-associated protein band was detected. That band was
cut out from the gel and reanalyzed by means of SDS-
PAGE revealing its relative molecular mass of 110 kD (data
not shown). This heme-binding protein also proved to
possess proteolytic activity against hemoglobin and it was
designated Hbp for hemoglobin protease (see below).
DNA Sequence of the HindIII–EcoRI Fragment of 12.6 kb.
Analysis of Hbp revealed the NH2-terminal amino acid
sequence GTVNNELGYQLFRD. This amino acid se-
quence was found to be 100% identical to that of the
deduced amino acid sequence of Tsh (temperature sensitive
hemagglutination; reference 34). The Tsh protein has a de-
duced molecular weight of 118,000 daltons and was found
to be significantly homologous to IgA1 proteases, a family
of proteins that are secreted by some pathogenic bacteria.
The resemblance in characteristics between Tsh detected in
the avian pathogenic E. coli strain 37122 and Hbp isolated
from a human pathogen suggests that the proteins are iden-
tical. A DNA probe was prepared based on the nucleotide
sequence of tsh and a 12.6-kb HindIII–EcoRI DNA frag-
ment was isolated by means of Southern blot experiments.
The nucleotide sequence of this fragment was determined
and analyzed for the location of open reading frames
(ORFs; Fig. 2). In total, 12 ORFs were detected (Table 1).
The amino acid sequences of the putative gene products
were searched for similarity to sequences reported previ-
ously in nonredundant protein data banks. The results are
summarized in Table 2. Hbp appears to be nearly identical
to Tsh (34). The minor differences found between the nu-
cleotide sequences of these two genes resulted in amino
acid substitutions Q209K and A842T. Other known genes
contained on the 12.6-kb DNA fragment are IS911, IS30
(35, 36), and genes that are part of the colicin V operon
(37). The enzyme IS30 is required for excising and insert-
ing mobile genetic elements (35). IS911 probably plays a
role in the translational frame shifting in the control of
transposition by IS30 (38). Whether these genes were in-
volved in rearrangements leading to the integration of the
hbp gene into its current position remains to be deter-
mined. Orf2 showed a high homology with fms, a gene
that encodes a deformylase (39). A high homology score
was also observed for orf3 and orf4 with two plasmid en-
coded genes y4hp and y4ho of Rhizobium sp. NGR234 (40).
The function of these genes is unknown. Orf5 and Orf6
showed reasonable homology to gene products of Mycobac-
terium tuberculosis (41) and Bacillus subtilus (these data are
available from GenBank/EMBL/DDBJ under accession
number Y14081), respectively. These two hypothetical
proteins show significant similarity to oxidoreductases.
Whether the putative genes located on the 12.6-kb DNA
fragment are involved in Hbp-mediated heme uptake or in
the secretion of Hbp remains to be determined.
Hbp Is Plasmid Encoded. DNA sequence analysis of the
HindIII–EcoRI DNA fragment of 12.6 kb showed that be-
sides hbp also a part of the colicin V operon is included in
this fragment (37). It is known that the structural colV genes
Figure 1. Purification of Hbp. Strain EB1 was cultivated in 5 l MA-
medium by gently shaking at 378C. At an OD660 of 0.6 the culture was
cooled to 48C and the bacteria were separated from the culture super-
natant by microfiltration (CFP-2-E-4A membrane cartridge [0.2 mm];
A/G Technology Corporation). The obtained culture supernatant was
concentrated a hundred times by using an ultrafiltration column (UFP-
10-C-4A membrane cartridge with a NMWC of 10,000; A/G Tech-
nology Corporation). A buffer exchange with 50 mM Hepes, pH 7,
was done during the concentration step. Six ml of concentrated culture
supernatant was then applied to a 0.8-ml POROS 20QE column (Per-
Septive Biosystems GmbH, Freiburg, Germany) equilibrated in 50
mM Hepes, pH 7. The column was washed with 8 ml Hepes and de-
veloped by a linear salt gradient of 50–200 mM KCl in Hepes. The
flow rate during the runs was 4 ml/min. 1-ml fractions were collected
and analyzed by SDS-PAGE. (A) POROS 20QE chromatography:
elution profile of Hbp. The arrow indicates the Hbp peak. (1) indi-
cates the concentration of KCl during the run (50–1,000 mM). (B)
SDS-PAGE profile (11% wt/vol) of samples taken at the two steps of
the purification process: the samples were TCA precipitated and ana-
lyzed by SDS-PAGE and Coomassie R-250 staining. Lane 1, molecu-
lar mass markers (kD); lane 2, the hundred times concentrated culture
supernatant (3.5 mg); lane 3, purified 110-kD protein (2.5 mg).1095 Otto et al.
are contained on so-called ColV plasmids (18, 31). There-
fore, we examined whether or not Hbp is plasmid en-
coded. An in vitro assay for colicin V production was used
to screen strain EB1. The strain was found to be positive
for colicin V production (data not shown). Strain LG1522
(pColV-K30) was used as a positive control strain. This
K-12 strain obtained the pColV-K30 plasmid by conjuga-
tional transfer from a wild-type strain (18). Immunoblot
analysis of the culture supernatant of LG1522 (pColV-K30)
with anti-Hbp antiserum showed that this strain expressed
Hbp on the same level as EB1 (Fig. 3). These results
strongly suggest that hbp in strain LG1522 is contained
on the pColV-K30 plasmid. Conjugational transfer of
the  EB1 pColV plasmid to the recipient strain AN299-
23(pACyC184) was performed to find evidence that in
EB1 hbp is also plasmid encoded. Based on the colocaliza-
tion of the hbp gene and the ColV operon, one should ex-
pect to find the presence of hbp in ColV1 transconjugants.
A ColV1 transconjugant, strain TC003, was isolated. Anal-
ysis of the restriction endonuclease profile of the plasmid
DNA from TC003 showed that this strain contains the
pColV plasmid from EB1 (data not shown). The pColV
plasmids of the wild-type strain EB1, LG1522 (pColV-
K30) and TC003 were used as templates in PCR experi-
ments. As shown in Fig. 4 A, lane 5, the transconjugant
TC003 contains the hbp gene, whereas the recipient strain
AN299-23 is lacking this gene (lane 4). These results dem-
onstrated that in strain EB1 hbp is plasmid encoded and in
strain LG1522 hbp is located on pColV-K30 (Fig. 4 A, lane
3). The pColV plasmids of strain EB1 and LG1522 were
also used as templates in Southern blot hybridization exper-
iments. The Southern blot hybridization profiles of the
plasmids from both strains appeared to be identical (Fig. 4 B).
Taken together, this strongly suggests that in strain EB1 hbp
is also located on a pColV-K30 plasmid, and that the gene is
located at z1908 of the genetic map of pColV-K30 (42).
Purification of Hbp from Culture Supernatants. Hbp was puri-
fied from concentrated culture supernatant of strain EB1 by
Table 1. Putative ORFs in the 12.6-kb DNA Fragment
ORF Endpoints Size of product Ribsosome binding site consensus sequence and initiation codon (bold)
nt aa
IS30 1 , 402* 383 TGCGGAGGTTTTTTGAATG
IS911 362 , 727 122 CAACACAGGTGCTCCAATG
orf1 823 . 1242 164 GCCTGAAGGAGATGAAATG
hbp 1368 . 5498 1377 TCAGGAGTAATTAAAAATG
orf2 5610 . 6056 143 ACATCTCTGGAGATTTATG
orf3 6486 , 7742 442 GGATAAACTCCGCCGGATG
orf4 7943 , 8287 115 TACAGGAACTGAAGCGATG
orf5 8926 , 9723 266 GCAGGAAAAAACACGTATG
orf6 9860 , 10738 293 CAAACAGCTCCCGTTTGTG
cvi 10929 . 11162 78 AATGGGATAAAAAGTAATG
cvaC 11143 .11451 103 ATAAAAAGGAGATCATATG
cvaB 11627 , 12606‡ 698
*ORF has been cut at the HindIII site. Total size of the original IS30 ORF is 1,151 nucleotides.
‡ORF has been cut at the EcoRI site. Total size of the original cvaB ORF is 2,096 nucleotides.
Figure 2. Organization of
ORFs of the 12,606-bp contig.
The scale is given in kb. The po-
sitions of the unique HindIII,
BamHI, and EcoRI sites and two
EcoRV sites are indicated. ORFs
are indicated by thick black ar-
rows and the arrowheads show
the direction of transcription/
translation. The names of the
genes are indicated above the ar-
rows; bold characters indicate
genes of which the nucleotide sequence has been published before, plain characters indicate newly discovered ORFs. Possible terminator structures and
promoter regions found by computer analysis are indicated by the symbol ( ) or a P, respectively. The position where the DNA-probe hybridized to the
12.6-kb fragment in Southern blot experiments is indicated by a straight line. The sequence data of this contig have been deposited in the EMBL Nucle-
otide Sequence Database under accession number AJ223631.
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ion exchange chromatography. The protein eluted from
the column between 80 and 120 mM KCl was free of con-
tamination by other proteins as shown by SDS-PAGE (see
Fig. 1). The fractions containing the purified protein were
pooled, quickly frozen and stored at 2808C. The amount
of 110-kD protein purified from one liter of culture super-
natant was z100 mg. The total quantity of 110-kD protein
secreted by EB1 in MA-medium was z300 mg/liter. The
culture supernatant of strain EB1 contained large amounts
of polysaccharide slime. Under anaerobic growth con-
ditions the production of these macromolecules was
enhanced, as was the production of Hbp. It was not pos-
sible to scale up the purification procedure, because the
POROS 20QE column was obstructed by these macro-
molecules during scaling up runs. To overcome this prob-
lem, strain E. coli DH5a(pHE12.6) was used to oversecrete
Hbp without the coproduction of a polysaccharide slime
(see Fig. 3). The quantity of 110-kD protein detected in
the supernatant of a culture from DH5a(pHE12.6) was
z2–4 mg/liter. The amount of purified protein obtained
from one liter culture supernatant of this strain was z1 mg.
Heme-binding Properties of Hbp. The heme-binding prop-
erties of Hbp were tested by incubating concentrated
supernatant proteins of strain EB1 with hemoglobin or
hemin, which is the oxidized form of heme. The mixtures
were subjected to nondenaturing PAGE and heme-associ-
ated protein bands were detected by chemiluminescence.
As shown in Fig. 5 B, Hbp was visualized by this assay indi-
cating that this protein can bind heme (lane 2). Further-
more, the protein was able to acquire heme from hemoglo-
bin (Fig. 5 B, lane 1). This implies that Hbp had to interact
with hemoglobin in such a way that heme will be released
from hemoglobin. A mechanism for the release of heme
could be a proteolytic degradation of hemoglobin by Hbp.
The heme-binding properties of Hbp were further inves-
tigated by heme affinity chromatography. The retention of
Hbp on hemin-agarose was examined by using a noncon-
centrated culture supernatant of strain DH5a(pHE12.6),
containing 40 nM Hbp. As shown in Fig. 5 A, lane 3,
retention of Hbp by this resin was observed. Pre- or coin-
cubation of the culture supernatant with 3–0.75 mM of
human hemoglobin could adequately inhibit the interac-
tion of Hbp with hemin-agarose (8 mM of ligand; Fig. 5 A,
lane 8–10). No inhibition of binding was observed after the
incubation of Hbp with protoporphyrin IX, the precursor
molecule of heme (Fig. 5 A, lane 7). The binding of Hbp
to hemin-agarose was not due to nonspecific ionic interac-
tions, because a high ionic strength washing buffer was
used in these experiments. Unexpectedly, a more profound
interaction of Hbp with hemin-agarose was detected by the
pre- or coincubation of the culture supernatant with low
concentrations of hemin (Fig. 5 A, lanes 4–6). At higher
concentrations of hemin ($ 50 mM) the interaction of Hbp
with hemin-agarose was prevented (data not shown). The
Table 2. Similarity of Predicted ORF Products to Proteins of Other Organisms
Product Similar protein in database Identity observed BLAST score
IS30 Transposase of E. coli 100%, from startcodon to HindIII restriction site 705
IS911 Hypothetical insertion element IS911 of E. coli 99%, entire length 621
Orf1 No significant similarities — —
Hbp Tsh gene product of E. coli 99%, entire length 6768
Orf2 Fms gene product of E. coli 98%, entire length 436
Orf3 Y4hP gene product of Rhizobium sp. NGR234 39–58%, entire length 299
Orf4 Y4hO gene product of Rhizobium sp. 53%, entire length 325
Orf5 MTCY31.20 gene product of Mycobacterium 32-42%, NH2-terminal part 116
tuberculosis, probably a mono-oxygenase
Orf6 yhjI gene product of Bacillus subtilis, probably a 29-45%, entire length 172
dehydrogenase
Cvi Immunity protein for colicin V of E. coli 100%, entire length 404
CvaC Colicin V protein of E. coli 100%, entire length 449
CvaB Export protein of colicin V of E. coli 100%, from EcoRI restriction site to stopcodon 1441
Figure 3. Analysis of the secretion of Hbp by the wild-type strain EB1,
DH5a carrying pHE12.6 or pBR322 and strain LG1522 carrying pColV-
K30. Supernatants of mid logarithmic phase cultures grown in MA-medium
were collected. The proteins in the supernatants were TCA precipitated,
separated by SDS-PAGE and immunodetected with anti-Hbp antiserum.
The amounts loaded are expressed as OD660 equivalents. Lanes 1 and 4, 1.0
OD660 units; lanes 2 and 3, 2.0 OD660 units.1097 Otto et al.
protein bound to hemin-agarose could be completely
eluted under nondenaturing conditions by using 3 mM hu-
man hemoglobin, 50 mM hemin or an 1 M NaCl and 20%
ethanol solution (data not shown). Taken together, the re-
sults demonstrate that Hbp is a heme-binding protein. In
addition to heme, hemoglobin was also capable to compete
very efficiently with hemin-agarose. Furthermore, these
data indicate that Hbp has a higher affinity for hemoglobin
than for hemin.
Hemoglobin Protease Activity. Hbp belongs to a group of
related proteins named the Tsh family (43). All members of
this family contain a consensus motif for the catalytic site
of serine proteases, suggesting that all these proteins are
proteolytic enzymes. Therefore, the recruitment of heme
from hemoglobin could be the result of a proteolytic
breakdown of hemoglobin by Hbp. A general protease assay
with denatured hemoglobin as substrate was used to detect
an endopeptidase activity by Hbp. As shown in Table 3, a
proteolytic activity of Hbp against denatured hemoglobin
was detected. To prove that this activity was caused by a
serine protease, the specific inhibitor 3,4-DCI, was used.
Indeed, preincubation of Hbp with this irreversible inhibi-
tor completely abolished the observed protease activities
(Table 3). A knockout mutant of Hbp (mutant mHbp18)
was obtained by site-directed mutagenesis experiments
with the suicide vector pSG-Hbp2.2 (see below). The cul-
ture supernatant of mutant mHbp18 showed almost no
proteolytic activity (Table 3). The observed background
activity by this strain is probably due to leakage of intracel-
lular enzymes into the growth medium. The insertion of
the kanamycin cassette into hbp in mHbp18 could also re-
sult in inactivation of the orf2 downstream of hbp by polar-
ity, since both genes are transcribed in the same orientation
(as shown in Fig. 2). Although a putative terminator struc-
ture was found between hbp and orf2, the possibility exists
that orf2 contributes to the proteolytic activity of Hbp. To
exclude this possibility strain DH5a(pBRHbp) was used in
the protease assay. This strain contains only the structural
hbp gene under control of its own promoter. Hbp is se-
creted by this strain (data not shown). A proteolytic activity
by DH5a(pBRHbp) comparable to that of EB1 was de-
tected (Table 3). This indicates that orf 2 is not responsible
for the observed proteolytic activity. Taken together, these
results indicate that Hbp is a serine protease.
An assay was developed to determine the specificity of
Hbp for hemoglobin. Native hemoglobin was incubated
with purified Hbp in a molar ratio of 1:3 at 378C for 4 h.
Subsequently, the protein samples were subjected to non-
denaturing gel electrophoresis and hemoglobin in the gel
was visualized by chemiluminescence. The intrinsic heme-
associated peroxidase activity of hemoglobin was initiated
by H2O2. Hydrolysis of hemoglobin by Hbp will give a re-
lease of heme and consequently a lower signal of hemoglo-
bin in this assay should be expected. The gel was also Coo-
massie R-250 stained to verify that the release of heme was
indeed due to a proteolytic activity of Hbp. As shown in
Fig. 6, both the chemiluminescence assay (A) and the Coo-
massie blue staining of the gel (B) revealed a decrease in he-
moglobin after the incubation with Hbp. The enzyme de-
graded hemoglobin in a pH range between pH 8.0 and 5.0,
but is optimally active on hemoglobin at pH 6.0 (lane 5).
Albumin, human lactoferrin and human immunoglobulin
A were not degraded by Hbp (data not shown). These re-
sults indicated that Hbp released heme from hemoglobin
by specifically degrading this protein.
Subcellular Localization of Hbp. Based on amino acid se-
quence homology between Tsh and immunoglobulin A1
proteases it was suggested that tsh encodes an IgA protease-
type exoprotein (34). Since Tsh and Hbp are quite similar,
this assumption also counts for Hbp. A common feature of
these so-called autotransporter proteins is that all necessary
translocation functions are carried by the polyprotein pre-
cursor itself and that these proteins are processed during
their translocation over the cell envelope (44). Based on se-
quence analysis of Hbp it should be expected that Hbp,
with a size of 110 kD, will be present in the cytoplasm and
cytoplasmic membrane as a 148-kD precursor, and in the
periplasm and outer membrane as a 142-kD intermediate
form. Subcellular localization experiments with the wild-
type strain EB1 and strain BL21(pET-Hbp) were per-
Figure 4. Screening of plasmid DNA on the presence of hbp by PCR and Southern blot hybridization experiments. The pColV plasmids of the wild-
type strain EB1, the K-12 strain LG1522 (pColV-K30) and the transconjugant TC003 were isolated, purified on an agarose gel and used as templates.
Strain TC003 obtained the pColV plasmid from EB1 by conjugational transfer. (A) Amplification of hbp by PCR. Primers used in these experiments
were the 110-forward and 110-reverse (see Materials and Methods). Lane 1, 1 kb DNA ladder; lane 2, wild-type strain EB1; lane 3, K-12 strain LG1522
(pColV-K30); lane 4, recipient strain AN299-23(pACyC184); and lane 5, transconjugant TC003. (B) Southern blot hybridization with a 1,022-bp long
DNA fragment from hbp as probe. Arrow points to 4,130-bp PCR product. Plasmid DNA of both strains was digested with various restriction enzyme
combinations and hybridized with the digoxygenin labeled 1,022-bp DNA fragment as probe. Single lanes represent plasmid digests with HindIII,
EcoRI, SacI, or SalI only (lanes 1–4, respectively) or EcoRI in addition to HindIII (lane 5), SalI (lane 6), SacI (lane 7).1098 Escherichia coli Hemoglobin Protease
formed to find these putative intermediary products of Hbp
in the cell. Strain BL21(pET-Hbp), that contains only the
structural hbp gene, was used to check if the gene product
indeed carries all the necessary translocation functions. In
addition, the effect of different growth temperatures on the
secretion of the protein by these two strains was examined.
As shown in Fig. 7 A, the wild-type strain EB1 was very
efficient in translocating Hbp across its cell envelope. At a
growth temperature of 378C only the mature protein was
found in the culture supernatant fraction (Fig. 7 A, lane 8,
bottom). The 148-kD precursor of Hbp was detected in the
cytoplasmic membrane fraction at 268C (Fig. 7 A, lane 2),
probably due to a hampered transport of the protein across
this membrane. The 142-kD intermediate of Hbp was not
found in the cellular fractions by this assay. The kinetics of
processing and transport of the protein through the cell en-
velope were probably too fast. In Neisseria gonorrhoeae,
comparable results in these kinetics have been found (44,
45). The kinetics of these processes were not influenced by
the lower growth temperature. Moreover, no difference
was found in the total amount of protein secreted at the
different growth temperatures (Fig. 7 A, lane 8).
The secretion of Hbp by strain BL21(pET-Hbp) at 378C
was similar to that of the wild-type strain, but in this strain
a significant accumulation of the 148-kD precursor was de-
tected in the cytoplasmic membrane at 378C (Fig. 7 B, lane
2). Furthermore, traces of the mature protein were de-
tected in the soluble and cytoplasmic membrane fractions
suggesting that part of the precursor of Hbp has been con-
verted into the mature form. At 268C these translocation
defects were even more pronounced (Fig. 7 B, top): almost
no secretion of Hbp occurred at this growth temperature
(lane 8).
Two independent hbp-knockout mutants were made by
site-directed mutagenesis (Fig. 8). Mutant mHbp18 was the
result of a double crossover event (Fig. 8 A). This mutant
lacks the expression of Hbp and loosed its proteolytic activ-
ity against hemoglobin (as shown in Table 3). The ex-
pected truncated Hbp of 52 kD was only detectable in total
cell lysates of mHbp18 at OD660 units of .2.0 in these im-
munoblot experiments (data not shown). The other mutant
(mHbp1) was mutated in the COOH-terminal part of
Hbp, due to a single crossover event (Fig. 8 B). The
COOH-terminal domain of IgA protease precursors pro-
vides the essential transport function for the proteases across
the outer membrane. Mutations in this so-called b-domain
blocked the translocation of the passenger proteins across
the membrane (44). Mutant mHbp1, lacks the last 84 bp at
the 39-end of the gene and expresses a truncated precursor
protein of 144.783 kD (Fig. 8 B, lane 2). Due to this muta-
tion secretion of Hbp in the environment was inhibited
(Fig. 8 B, lane 3). These results strongly suggested that Hbp
is an autotransporter, but the efficiency of the translocation
of this protein over the cell envelope depends on the host
that is used.
Discussion
E. coli possesses four iron uptake systems that use sidero-
phores such as enterobactin and aerobactin, produced by E.
coli, or the fungal siderophores ferrichrome and coprogen.
Iron acquisition by this bacterium can also occur in a pro-
cess mediated by citrate (1, 5). Pathogenic E. coli strains are
able to use heme compounds as iron sources, but so far lit-
tle is known about the mechanisms involved in this kind of
iron uptake (10). The results of this study suggest that the
human pathogenic E. coli strain EB1 contains a hemo-
Figure 5. Heme-binding prop-
erties of Hbp. (A) Isolation of
Hbp by hemin affinity chroma-
tography and binding specificity
as measured by competition
experiments. 50 ml of culture
supernatant of strain DH5a-
(pHE12.6) was incubated with
hemin-agarose, as described in
Materials and Methods. Lane 1,
marker proteins (in kD); lane 2,
Hbp not retained on hemin-aga-
rose; lane 3, Hbp retained on
hemin-agarose alone; lanes 4–6,
Hbp retained in the presence of
15, 3 and 1.5 mM hemin (Hm);
lane 7, Hbp retained in the pres-
ence of 15 mM protoporphyrin
IX (Pp); lanes 8–10, Hbp re-
tained in the presence of 3.0,
1.5, and 0.75 mM hemoglobin.
(B) Detection of heme-protein
complexes in a nondenaturing
polyacrylamide gel system. Con-
centrated supernatant proteins of
strain EB1 were incubated with
hemin or hemoglobin for 1 h.
Samples of these mixtures were
run on a 11% polyacrylamide
gel. Heme-associated protein
bands in the gel were visualized
by means of chemiluminescence
as described in Materials and
Methods. Lane 1, supernatant proteins incubated with hemoglobin; lane
2, supernatant proteins incubated with hemin. The positions of heme-sat-
urated Hbp and hemoglobin in the gel are indicated.1099 Otto et al.
phore-dependent heme acquisition system. The bacterium
secretes a heme-binding protein (Hbp) with an estimated
size of 110 kD, that degrades hemoglobin. It is likely that
Hbp is the shuttle protein of this heme-scavenging system
in E. coli.
Recently, an exported protease (PssA) from a Shiga
toxin-producing E. coli has been characterized (43). Se-
quence comparison showed that PssA is related to the fam-
ily of autotransporter proteins, especially to SepA of S. flex-
neri (46), Tsh of E. coli (34) and EspC from EPEC (47).
These proteins belong to a family of proteins that is only
distantly related to the IgA1 proteases of Neisseria and Hae-
mophilus (43). It was proposed to designate this group of re-
lated proteins the Tsh family. The protein PssA showed a
moderate serine protease activity in a casein-based assay.
The conservation of the putative catalytic center of serine
proteases in all members of the Tsh family suggests similar
proteolytic activities for these proteins. However, the natu-
ral substrate for these proteins remained unclear because
casein is unlikely to be the natural substrate. We found that
Hbp has a high affinity to hemoglobin and acquires its
heme from hemoglobin by degradation of this protein. It is
tempting to speculate that hemoglobin is also the natural
substrate for the other members of the Tsh family. An ac-
tivity of z300 pmol/h/mg of Hbp was found and the en-
zyme showed a pH optimum of 6.0–6.5, which is consis-
tent with the physiological pH during an infection, since at
the site of infection the pH will fall to 6.0 in response to in-
flammation.
This study shows that elution of Hbp from hemin-aga-
rose is possible with hemin or hemoglobin. Otherwise, very
rigid conditions, like boiling the beads in denaturing buff-
ers or high salt buffers, are needed to elute Hbp from
hemin-agarose, indicating high affinity binding of Hbp to
hemin and hemoglobin. Hbp shares these characteristics
with HasA of S. marcescens, a heme-binding shuttle protein
responsible for the uptake of heme from hemoglobin by an
unknown mechanism (9). We demonstrated that Hbp can
obtain heme from hemoglobin by a proteolytic interaction.
A remarkable observation in the heme affinity chromatog-
raphy experiments was that low concentrations of free
heme molecules favor the binding of Hbp to hemin-aga-
rose. Presumably, heme induced a conformational change of
Hbp in such a way that the protein gets a higher affinity to
hemin-agarose. This suggests the presence of two heme-
binding sites in Hbp, one with a moderate and the other
with a high affinity for heme.
Hbp has to be shuttled back to the cell surface if it is in-
volved in a heme-acquisition system. Hence, E. coli must
possess a specific outer membrane receptor that will recog-
nize the heme-saturated Hbp protein. Results of prelimi-
Table 3. Detection of a Proteolytic Activity by Hbp
Samples Activity
Activity
with 3,4 DCI Specific activity Activity
units units units/mg %
Supernatant of strain EB1 0.40 0.18 220 100
Purified Hbp from nonconcentrated supernatant 0.42 0.00 168 76
Purified Hbp from concentrated supernatant 0.69 0.00 69 31
Supernatant of mHbp18 0.01 ND — —
Supernatant of DH5a(pBRHbp) 0.30 ND 200 91
Culture supernatants of the different strains were collected at an OD660 of 0.6. The obtained supernatant of the wild-type strain EB1 was concen-
trated a hundred times and then applied to a POROS 20QE column, or fresh supernatant was directly run on this column (Fig. 1). The knockout
mutant mHbp18 lacks the expression of Hbp (as shown in Fig. 8 A). Strain DH5a(pBRHbp) contains only the structural hbp gene under control of
its own promoter. The samples of the different supernatants and the POROS 20QE eluates were incubated with denatured hemoglobin (pH 6.5) at
37°C for 10 min. The serine protease inhibitor 3,4-dichloroisocoumarin (3,4-DCI, 3 mM) was preincubated with Hbp at 30°C for 30 min.
Figure 6. Hemoglobin protease activity by Hbp at different pH. He-
moglobin was incubated with purified Hbp, as described in Materials and
Methods. Samples were analyzed by nondenaturing PAGE and PhotoIm-
aging. (A) Hemoglobin visualized by means of chemiluminescence. Lane
1, hemoglobin not incubated with Hbp, pH 6.0; lanes 2–5, hemoglobin
incubated with Hbp at pH 8.0, 7.0, 6.5, and 6.0, respectively. A quantita-
tion of the PhotoImage data is presented at the right hand of the image.
The initial amount of hemoglobin present in the reaction mixture was set
at 100%. (B) Hemoglobin visualized by means of Coomassie R-250 stain-
ing. Lanes 1–5, same samples as in A.1100 Escherichia coli Hemoglobin Protease
nary studies suggested that E. coli indeed has a receptor that
is able to discriminate between the apo- and holo-form of
Hbp (unpublished results). Recently, a putative 69-kD
heme receptor (ChuA) in E. coli has been described (48).
Utilization of heme and hemoglobin by E. coli was ChuA
dependent. It would be of interest to find out whether this
receptor is also involved in the Hbp-mediated heme up-
take. Work is in progress to further characterize the recep-
tor for Hbp in E. coli EB1.
This study also demonstrates that hbp is located on
pColV-K30. The pColV-K30 plasmid (144 Kbp) belongs
to a heterogeneous group of virulence plasmids (42). The
plasmids encode the production of a colicin known as coli-
cin V and are commonly found in invasive strains of E. coli
from human and domestic animals (18). ColV plasmids en-
code several virulence-related properties in addition to co-
licin V (42). One of the properties that clearly contributes
to the virulence of pColV-K30 is the aerobactin iron as-
similation system. This shuttle-mediated iron uptake system
has been extensively reviewed (5, 11, 42). It seems that
pColV-K30 encodes two shuttle-mediated iron uptake sys-
tems; one for the acquisition of iron and another for heme.
It would be of great interest to find out if these two iron
uptake systems are in some way related. In pColV-K30 hbp
is located on a HindII–BamHI DNA fragment of 6,453 bp.
We examined HindIII–BamHI restriction enzyme profiles
of different pColV plasmids (42) for the presence of similar
sized HindII–BamHI DNA fragments. The profiles reveal
DNA fragments of z6,500 bp in pColV-292, pColV-F70
and pColV-F54, suggesting that hbp is present in these plas-
mids. We propose that Hbp contributes to the virulence
properties of pColV plasmids.
We show that Hbp is synthesized as a polyprotein pre-
cursor which is processed following export to the cell sur-
face. The kinetics of protein translocation across the outer
Figure 7. Subcellular localization of Hbp. Cells of the wild-type strain
EB1 (A) and IPTG-induced cells of strain BL21(pET-Hbp) (B) were
grown in LB medium at 268C and 378C. Outer membrane (OM), inner
membrane (IM) and crude membrane (M) fractions were derived from
1.3 OD660 units. Soluble (S), membrane and soluble (M1S), cellular de-
bris (D), and total lysate (T) fractions were derived from 0.33 OD660 units.
Culture supernatant (Sup) fractions were derived from 3.0 OD660 units.
The fractions were analyzed by immunoblotting with the anti-Hbp anti-
serum. The secretory intermediates of Hbp and molecular mass markers
(kD) are indicated at the right and left side of the panels, respectively.
Figure 8. Analysis of the expression of Hbp by Hbp-mutants. The mu-
tants mHbp18 and mHbp1 were obtained by site-directed mutagenesis
experiments with the suicide vectors pSG-Hbp2.2 and pSG-Hbp4.8, re-
spectively. See Materials and Methods for a detailed description of the
construction of these suicide vectors. Culture supernatant fractions and
total lysate fractions were derived from 4.0 and 0.5 OD660 units, respec-
tively. The fractions were analyzed by immunoblotting with the anti-Hbp
antiserum. (A) Expression of Hbp by mHbp18. Lanes 1 and 4, lysate and
supernatant of the wild-type strain EB1; lanes 2 and 3, lysate and superna-
tant of mHbp18. (B) Expression of Hbp by mHbp1. Lanes 1 and 4, same
samples as in A; lanes 2 and 3, lysate and supernatant of mHbp1. The
secretory intermediates of Hbp and molecular mass markers (kD) are indi-
cated at the right and left side of the panels, respectively. A schematic rep-
resentation of the recombination events of the suicide vectors is depicted
at the right side of this figure. Mutant mHbp18 was the result of a double
crossover and mutant mHbp1 of a single crossover event. Symbols in this
diagram are: M, MluI restriction site; P, promoter; km, kanamycin cas-
sette.1101 Otto et al.
membrane and subsequent cleavage are very rapid, whilst
the transfer through the cytoplasmic membrane appears to
be a slower process. Hbp is also efficiently secreted by a
K12-strain in which the structural hbp gene was intro-
duced. Furthermore, secretion of Hbp is inhibited by a
mutation in the b-domain of its precursor. Comparable re-
sults were found for the IgA protease of N. gonorrhoeae (44,
45). These results strongly suggest that Hbp is an autotrans-
porter protein. Autotransporters are large polyproteins that
are organized in functional domains and are eventually pro-
cessed at the cell surface. The necessary translocation func-
tions are carried by the polyprotein precursor itself. The
b-domain of the precursor is responsible for the transport of
the protein across the outer membrane (44). However, in
strain BL21(pET-Hbp) we found that the secretion of the
protein was less efficient. Accumulation of the 148-kD
precursor in the cytoplasmic membrane and traces of the
mature protein were detected in the periplasmic and cyto-
plasmic membrane fractions of this strain. Accumulation
of the 148-kD precursor in the membrane might cause
changes in the conformation of the precursor in such a way
that the proteolytic site of the b-domain becomes accessi-
ble to periplasmic proteases. It seems that the efficiency of
transport across this membrane and or cleavage of the signal
peptide is dependent on the host type used. Thus, it cannot
be excluded that other, yet unknown factors are involved
in this pathway of secretion.
It has been shown that tsh is responsible for a mannose-
resistant hemagglutination activity in E. coli (34). This ac-
tivity was best expressed at 268C. However, it remains un-
clear which role an extracellular Tsh protein might play in
hemagglutination, since microbial adhesins are normally
membrane-associated.  E. coli strain EB1 was also tested for
its ability to agglutinate erythrocytes from human and dif-
ferent animals. The EB1 cells were cultured under different
conditions and subsequently tested as described in Materials
and Methods. Purified Hbp, outer membrane proteins and
concentrated culture supernatants were also tested for hem-
agglutination activity. None of these experiments yielded a
positive reaction (data not shown). The reason for the ap-
parent difference between Hbp and Tsh in hemagglutina-
tion activity remains unclear. It seems that only under very
specific conditions hemagglutination activity by Tsh can be
detected.
Recently, the complete nucleotide sequence was deter-
mined of the plasmid from Rhizobium sp. NGR234 that
endows the bacterium with the ability to associate symbiot-
ically with leguminous plants (40). The results of this study
showed that pNGR234a has functioned as a transposon
trap. Potential genes detected on this plasmid appear to be
all involved in the symbiosis between Rhizobium and le-
gumes. No genes essential for transcription, translation or
primary metabolism were found (40). Presumably, colicin
V virulence plasmids also function as ‘transposon traps’ and
consequently these plasmids may only contain virulence
genes. Therefore, it will be interesting to clarify the func-
tions of the orfs located on the 12.6-kb DNA fragment.
In conclusion, the results of this study demonstrate that
Hbp is a heme-binding protein that obtains its heme from
hemoglobin by degradation of this protein. The protein is
likely to be the shuttle protein of a hemophore-dependent
heme acquisition system in this human pathogenic E. coli
strain. Hbp is a member of the Tsh family and its structural
gene is located on a ColV virulence plasmid. All these
characteristics strongly suggest that Hbp is an important
virulence factor that may play a significant role in the
pathogenesis of E. coli infections. However, the role of this
protease as a virulence factor remains to be tested in vivo.
Further studies are needed to prove if the other IgA1 pro-
tease-like autotransporters are also heme-binding proteins
with a proteolytic activity specific for hemoglobin. We are
currently investigating the nature of binding of Hbp at the
cell surface of E. coli and the proteolytic properties of the
protein in more detail.
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